“…51,52 A large multicenter trial in the UK, however, found higher rates of grade 3 PGD, need for post-transplant ECMO, significantly increased cost, and almost double the one year mortality for patients who received EVLP lungs. 53 Although the authors caution drawing conclusions given the small number of patients involved (18 in the EVLP arm) and a change in the EVLP protocol midway through the trial, these findings suggest that further standardization of EVLP techniques may be necessary to allow effective, wide-spread adoption of this technology.…”